CD19 and acute lymphoblastic leukemia: CD19 modulation occurs through a variety of mechanisms18–26 and is thought to be the primary mechanism of tumor escape in r/r B-ALL, occurring in 7–28% of r/r B-ALL CRs, is a major determinant for response durability, and is associated with poor prognosis3,5–10,13,14,27–30.